Claire Hobbs
Swindon College(GB)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Advanced Radiotherapy Techniques, Meningioma and schwannoma management, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial(2021)725 cited
- → ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.(2019)226 cited
- → Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer(2021)183 cited
- → Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance(2022)52 cited
- → Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply(2021)7 cited
- → High Quality Clinical Stereotactic Radiosurgery Planning and Delivery With Standard Resolution (5 mm) Multileaf Collimation and Multiple Isocenters(2020)5 cited
- → Surgical and oncological score to estimate the survival benefit of resection and chemoradiotherapy in elderly (≥70 years) glioblastoma patients: A preliminary analysis(2022)5 cited
- → Significance of alterations in DNA damage repair (DDR) genes in advanced biliary cancers (ABCs) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 trial.(2023)5 cited
- → Lipoproteins in non-insulin dependent diabetes mellitus (NIDDM)(1996)2 cited
- → Role of the Neuroradiologist and Neurosurgeon in Contouring with the Clinical Oncologist for Stereotactic Radiosurgery(2022)2 cited